Evidence map›Paper›PMID 27585023›Full record

ArticleHealthcare policy = Politiques de sante2016

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Steven G Morgan, Marc-André Gagnon, Barbara Mintzes, Joel Lexchin

Abstract read
In one paragraph

Article in Healthcare policy = Politiques de sante, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Ontario and New Zealand Pharmaceuticals: Cost and Coverage.Healthcare policy = Politiques de sante · 2018
    Article
  6. Drug prices: How do we get to a better place?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Article
  7. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Steven G MorganProfessor, School of Population and Public Health, University of British Columbia, Vancouver, BC.
Marc-André GagnonAssociate Professor, School of Public Policy and Administration, Carleton University, Ottawa, ON.
Barbara MintzesSenior Lecturer, Faculty of Pharmacy, University of Sydney, Sydney, Australia.
Joel LexchinProfessor, Faculty of Health, York University, Toronto, ON.

Funding

CIHR
6 · The paper itself

Abstract

Canada needs a national strategy to fulfill its obligation to ensure universal access to necessary healthcare, including prescription drugs. A 2004 attempt at a national strategy for pharmaceutical policy failed because it lacked clear vision, logical planning and commitment from federal and provincial governments. The result of uncoordinated pharmaceutical policies in Canada has been more than a decade of poor system performance. In this essay, we present a framework for a renewed national strategy for pharmaceutical policy. Building on published research and international frameworks, we propose that pharmaceutical policies of federal, provincial and territorial governments be coordinated around a core health-focused goal. We strongly suggest policy actions be taken on four core objectives that are necessary to support the overarching health goal. If implemented, the proposed strategy would offer clear benefits to all Canadians who use medicines, federal and provincial governments and to the economy as a whole. We therefore argue that political leadership is now needed to articulate and implement such a plan on behalf of Canadians.

Indexed as

Health PolicyLegislation, DrugCanadaDrug ApprovalHealth Services AccessibilityHumansPrescription DrugsPrescription Drugs

Identifiers

PMID27585023
PMCPMC5008128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.